跳至主要内容
临床试验/NCT00694408
NCT00694408终止3 期

A Randomized Pilot Trial of a Steroid-free Immunosuppressant Regimen in Pediatric Liver Transplantation

Birmingham Women's and Children's NHS Foundation Trust1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2008年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
发起方
入组人数
15
试验地点
1
主要终点
Primary endpoint: The development of histologically proven acute rejection. (within 12 months

研究概览

简要总结

Objective:

The overall objective is to investigate whether a steroid free immunosuppressive regimen is as safe and effective as a steroid containing regimen following pediatric liver transplantation and whether it promotes tolerance.

详细描述

3.2 Research question

Is it possible to avoid the use of corticosteroids in pediatric liver transplantation?

3.3 Trial objectives

This will be a pilot study to

i) investigate to what degree a steroid free immunosuppressive regimen is as safe and effective as a steroid containing regimen following pediatric liver transplantation

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Day 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Children undergoing primary isolated hepatic transplantation.
  • Age <=18 years
  • Ability to provide informed consent

排除标准

  • Children undergoing retransplantation.
  • Transplantation for Intestinal failure associated liver disease.
  • Multi-organ transplantation.
  • Transplantation for autoimmune liver disease.
  • Transplantation for extra hepatic malignancy.
  • Pre-existing need for oral steroids, or high dose inhaled steroids sufficient to require a steroid warning card.

研究组 & 干预措施

Steroid immunosuppressive regimen

Active Comparator

Freedom from rejection and safety in children undergoing paediatric liver transplant using steroid containing immunosuppression regimen post transplant. This group of patients will receive steroids in conjunction with other prescribed immunosuppressive agents. Intervention is use of methyl prednisolone, hydrocortisone, prednisolone as routine post transplant management

干预措施: methyl prednisolone, hydrocortisone, prednisolone (Drug)

Steroid free immunosuppressive regimen

Active Comparator

Freedom from rejection and safety in children undergoing paediatric liver transplant using steroid free immunosuppression regimen post transplant. The patients in this arm will receive immunosuppression but not steroids to compare with those treated with steroids to measure differences in rejection and safety of a steroid free immunosuppressive regimen. Intervention is omission of methyl prednisolone, hydrocortisone, prednisolone as routine post transplant management. No steroids will be used routinely in this arm

干预措施: No steroids (Other)

结局指标

主要结局

Primary endpoint: The development of histologically proven acute rejection. (within 12 months

时间窗: 12m

次要结局

  • The development of steroid resistant acute rejection 12 months. The expression of tissue and circulating markers of immune tolerance in first year post transplant The incidence of infection in the first year post transplant(12m)

研究者

发起方
Birmingham Women's and Children's NHS Foundation Trust
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验